IMMUNE-MEDIATED MUCOSITIS

This adverse event was reported 44 times

IMMUNE-MEDIATED MUCOSITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEMIPLIMAB-RWLC 1 0.0005
1 METHYLCELLULOSE 1 0.0004
2 EPIRUBICIN HYDROCHLORIDE 1 0.0002
3 PACLITAXEL 10 0.0001
4 CARBOPLATIN 12 0.0001
5 NIVOLUMAB 7 0.0001
6 IPILIMUMAB 3 0.0001
7 PEMETREXED DISODIUM 2 0.0001
8 AXITINIB 1 0.0001
9 DURVALUMAB 1 0.0000
See all drugs enriched for association with IMMUNE-MEDIATED MUCOSITIS